News

A consortium of Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I has reached a binding agreement to buy a majority stake in Germany-based diagnostic imaging specialist RAD-x from specialised healthcare investor Gilde Healthcare.Candesic provided commercial due ...

Read more

Candesic is pleased to have assisted HBSUK with vendor commercial due diligence on its acquisition by insurance giant AXA Health on Friday. HBSUK supports public and private healthcare providers in reducing waiting lists and giving rapid access to healthcare professionals, whether ...

Read more

We are pleased to announce that Candesic provided vendor commercial due diligence to Centene Corporation in the context of their sale of Operose Health to HCRG Care Group. Operose Health is a UK leader in delivering exceptional NHS care to hundreds of thousands of patients nationwide ...

Read more

Congratulations to the team at TPG on their majority investment in Outcomes First Group! Candesic provided commercial due diligence to TPG. Outcomes First Group is a leading provider of education and care for children, young people, and adults with special educational needs (SEN) and ...

Read more

Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners. Julius Clinical is a leading academic clinical CRO providing clinical trial services and real-world evidence ...

Read more

Congratulations to NorthEdge on their acquisition of Torbay Pharmaceuticals. Candesic provided commercial due diligence to NorthEdge. Torbay Pharmaceuticals is a fast growing specialist sterile injectable contract manufacturer. The investment will strengthen capabilities and accelerate ...

Read more

Candesic is pleased to have provided commercial due diligence to Mayden,  the leading electronic health record (EHR) for psychological therapies in the UK, in the context of their newly announced partnership with G Square Healthcare Private Equity LLP a leading European healthcare ...

Read more

Gyrus Capital acquired LRE Medical, a provider of high-quality engineering solutions and manufacturing for medical equipment and life science diagnostics. Both companies continue to provide customers with market-leading point-of-care diagnostic solutions. Gyrus Health has entrusted Candesic ...

Read more

Circle Health Group, the largest UK independent hospital operator, is to be sold for ca £1bn to PureHealth, the largest integrated healthcare network in the United Arab Emirates. The transaction is expected to bring significant benefits to the healthcare ecosystems of both ...

Read more

Our team had the privilege of advising Gresham House Ventures on the investment into Mable Therapy. Mable Therapy is the UK’s leading digital health platform for children’s speech and language therapy and counselling services. Over 3,000 children have received therapy from Mable in the last ...

Read more